Totally implantable central venous access ports in patients with cystic fibrosis: A multicenter prospective cohort study

Journal of Vascular Access

Volumn 13, Issue 3, 2012, Pages 290-295

  Dal Molin, Alberto ^a   Di Massimo, Dino Stefano ^b   Braggion, Cesare ^c   Bisogni, Sofia ^c   Rizzi, Elena ^d   D'Orazio, Ciro ^d   Di Toppa, Maria Vittoria ^e   Alghisi, Federico ^e   Cristadoro, Simona ^f   Carnovale, Vincenzo ^g   Festa, Gabriella ^g   Rampini, Serena ^h   Colombo, Carla ^h   Oneta, Anna ^h   Furnari, Maria Lucia ⁱ   Calamia, Maria Antonietta ⁱ   Zunino, Maria Luisa ^j   Tuccio, Giuseppe ^k   Spadea, Vincenzo ^k   Messore, Barbara ^l   Grosso, Bianca ^l   Festini, Filippo ^m   more..

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Biella Hospital   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CF Center of Verona   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f UNIVERSITY OF MESSINA   (Italy)

^g FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ CF Center of Palermo Children Hospital 'Di Cristina'   (Italy)

^j G GASLINI INSTITUTE   (Italy)

^k CF Center of Soverato Soverato Hospital   (Italy)

^l SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^m UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

Catheter; Cystic fibrosis; Nursing; Totally implantable vascular devices

Indexed keywords

ADULT; ARTICLE; CATHETER INFECTION; CATHETER OCCLUSION; COHORT ANALYSIS; CYSTIC FIBROSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; TOTALLY IMPLANTABLE VENOUS ACCESS DEVICE; VASCULAR ACCESS DEVICE; VEIN THROMBOSIS;

EID: 84870358309     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000036     Document Type: Article

References (30)

1. Buzzetti R, Baronciani D, Mastella G, et al. Screening neonatale della fibrosi cistica - Una rassegna della letteratura. Ed. Fondazione Ricerca Fibrosi Cistica. Ottobre 2008.
2. Littlewood J, Balfour-Lynn I, Barnes R, et al. Standards for the Clinical care of Children and Adults with Cystic Fibrosis in the UK 2001. UK CF Trust 2001.
3. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92(4):706-712.
4. Munck A, Malbezin S, Bloch J, et al. Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J. 2004;23: 430-434.
5. Ballarin S, Milella I, Bergamin L, Festini F. Use of central venous catheters in people with cystic fibrosis in Italy. J Cyst Fibros. 2007;6(suppl 1):81.
6. Batacchi S, Zagli G, Peris A, Braccini G, Bresci S. Totally implantable vascular access devices in adult patients for cystic fibrosis management. Am J Respir Crit Care Med. 2011; 1;183(1):133-134.
7. Farrell PM, Rosenstein BJ, White TB, et al. Cystic Fibrosis Foundation: Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-S14.
8. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M. ESPEN. ESPEN guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009; 28(4):365-377.
9. Biffi R, de Braud F, Orsi F, et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998;9(7):767-773.
10. Royle TJ, Davies RE, Gannon MX. Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients. Ann R Coll Surg Engl. 2008;90(8): 679-684.
11. Burdon J, Conway SP, Murchan P, Lansdown M, Kester RC. Five years' experience of PAS Port intravenous access system in adult cystic fibrosis. Eur Respir J. 1998;12:212-216.
12. Sola JE, Stone MM, Wise B, Colombani PM. Atypical thrombotic and septic complications of totally implantable venous access devices in patients with cystic fibrosis. Pediatr Pulmonol. 1992;14(4):239-242.
13. Ball AB, Duncan FR, Foster FJ, Davidson TI, Watkins RM, Hodson ME. Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir Med. 1989;83(5):429- 431.
14. Rodgers HC, Liddle K, Nixon SJ, Innes JA, Greening AP. Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions. Eur Respir J. 1998;12: 217-220.
15. Kariyawasam HH, Pepper JR, Hodson ME, Geddes DM. Experience of totally implantable venous access devices (TIVADs) in adults with cystic fibrosis over a 13-year period. Respir Med. 2000;94(12):1161-1165.
16. Deerojanawong J, Sawyer SM, Fink AM, Stokes KB, Robertson CF. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax 1998;53:285-289.
17. Horn CK, Conway SP. Candidaemia: risk factors in patients with cystic fibrosis who have totally implantable venous access systems. J Infect. 1993;26(2):127-132.
18. Pratt RJ, Pellowe CM, Wilson JA, et al. Epic2: National Evidence-Based Guidelines for Preventing Healthcare-associated Infections in NHS Hospitals in England. J Hosp Infect. 2007;65S, S1 S64.
19. Biffi R, Pozzi S, Agazzi A, et al. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol. 2004;15(2):296-300.
20. Yildizeli B, Laçin T, Batirel HF, Yüksel M. Complication and management of long-term central venous access catheters and ports. J Vasc Access 2004;5(4):174-178.
21. Gallieni M, Pittiruti M, Biffi R. Vascular Access in Oncology Patients. CA Cancer 2008; 58:323-346.
22. RNAO Guidelines: Registered Nurses Association of Ontario. Care and Maintenance to Reduce Vascular Access Complication. Nursing Best Practice Guideline; 2005 - revised 2008.
23. RCN Guidelines: Royal College of Nurses: Standards for Intravenous Infusion; 2005
24. Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ, Krzywda EA, Andris DA. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology 1990;1:353-356.
25. Arch P. Port navigation: let the journey begin. Clin J Oncol Nurs. 2007; 11 (4), 485-488.
26. Dougherty L. Maintaining vascular access devices: the nurse's role. Support Care Cancer. 1998;6:23-30.
27. Dougherty L. Central Venous Access Devices e Care and Management. Blackwell Publishing, Oxford. 2006.
28. Vescia S, Baumgärtner AK, Jacobs VR, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19(1):9-15.
29. Kuo YS, Schwartz B, Santiago J, Anderson PS, Fields AL, Goldberg GL. How often should a port-A-cath be flushed? Cancer Invest. 2005;23(7):582-585.
30. A-Rahman A, Spencer D. Totally implantable vascular access devices for cystic fibrosis. Cochrane Database of Systematic Reviews 2003;(3):CD004111.